In Pharmaceutical Manufacturing Construction and Technology
At procurement, qualification and validation
There is a common misconception that “bio-based” means “compostable” or “weak.” In the high-stakes world of biopharmaceutical manufacturing, that couldn’t be further from the truth.
As we scale up single-use technologies (SUT) in 2026, understanding the origins and particularities of these materials is a compliance and sustainability imperative.
As we move through 2026, the biopharma industry is hitting a major sustainability milestone. For years, the move to Single-Use Technology (SUT) was criticized for its plastic waste. Today, one step towards solving that paradox that has been presented is Bio-based Polymers.
Today, we’re proud to introduce Owen McMaster, our motivated and resourceful Project Manager / Engineer-in-Training (EIT).
Today, we’re proud to introduce the professional who bridges complex engineering with validated execution: Colin Young, our Project Manager and Validation Scientist.
Copyright (c) 2025, GPharma Solutions Ltd; all rights reserved.
Template by Bootstrapious. Ported to Hugo by DevCows.
